Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab. [PDF]
Mitra D +3 more
europepmc +1 more source
Digital assets: risks, regulations, mitigation. [PDF]
Teng HW +30 more
europepmc +1 more source
Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis. [PDF]
Mar K +7 more
europepmc +1 more source
Blockchain Technology Predictions 2024: Transformations in Healthcare, Patient Identity, and Public Health. [PDF]
De Novi G +4 more
europepmc +1 more source
Cytomorphological Spectrum and Diagnostic Utility of Tzanck Smear Cytology in Vesiculobullous Skin Lesions: A Cross-Sectional Study From a Tertiary Care Center in Eastern Uttar Pradesh, India. [PDF]
Gautam P +5 more
europepmc +1 more source
Halfway Through Ex Situ Population Genetic Lifespan: The Case of <i>Cochlearia polonica</i>. [PDF]
Rucińska A +6 more
europepmc +1 more source
Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient. [PDF]
García-Paz V +5 more
europepmc +1 more source
The "String of Pearls" Sign of Chronic Bullous Disease of Childhood (CBDC). [PDF]
Tripathy DM, Saraswat N, Kumar S.
europepmc +1 more source
The rise in popularity of central bank digital currencies. A systematic review. [PDF]
Prodan S +4 more
europepmc +1 more source
Implementation opportunities and challenges to piloting a community-based drug-checking intervention for sexual and gender minority men in Vancouver, Canada: a qualitative study. [PDF]
Coulaud PJ +6 more
europepmc +1 more source

